#CAC40 #SP500
Now politicians throughout Europe have finally ceased pandering to baseless media stories regarding their vaccine, hopefully the company share price shall continue to show improvement. From a personal standpoint, the initial jags from AZN.L proved truly impressive, causing a measurable improvement in the immune system.
For instance, days before receiving the initial doze, a full blood workup in hospital revealed a Platelet count of 48. This is a bad thing, at risk of internal bleeding but worse, even shaving left my face looking like a victim of a slasher attack until all the tiny, invisible, wounds healed. In addition, waking up to discover the bedding had transformed into a Turin Shroud knock-off, was a little frightening. This particular state of affairs had been going on for months, thanks to a particular chemotherapy regime. But the first Covid-19 vaccine administered was from Astrazeneca and again, days later at the hospital, my bloodwork revealed an astounding change. The Platelet count had almost doubled, bedding was no longer covered in blood, and shaving returned to being a morning chore. There was slight slippage in the platelet count over the next few months but it returned to the high 80’s following the 2nd Astrazeneca shot.
For me, anyway, I was sold on possible benefits as there was literal proof it improved whatever was going on inside my body. As an added bonus, I didn’t catch Covid-19 though perhaps this was equally related to the utter paranoia of a cancer patient going through treatment. Plus, what folk in cities called “Lockdown”, here in Argyll we called it Tuesday, thanks to the benefit of low population density.
The foregoing probably reveals a bias in favour of Astrazeneca products but the bias has not caused the encouraging position of the company share price.
Back in 2020, flushed with success at being first to the market, AZM share price experienced a spike to 10,120p. As the chart shows, the months following paid for this optimism, politicians throughout Europe actively sabotaging the companies efforts while hoping their national manufacturers could catch up. All things considered, the entire affair was messy. Recent comments on a BBC documentary suggested “bad behaviour from scientists and from politicians has probably killed hundreds of thousands of people – and that they cannot be proud of that...” The AZN vaccine was cheaper, easier to distribute, and again from a personal viewpoint, effective.
Closing Wednesday 30th at 10,160p, the share price now is confirmed in strong territory for the longer term. Even from an immediate perspective, at calculates with movement above 10,165 potentially triggering a nod in the direction of 10,846 next. We’ve a bunch of separate formula promoting this as a target level and generally, when this happens, confidence is fairly high.
Our longer term secondary target is slightly confusing as it demands the price close a session above 10,846p to become “real”. Apparently above 10,846p could produce ongoing travel toward 11,906p, perhaps even 12,608p. This massive difference in target ambitions can be laid squarely at the feet of July 20th, 2020 and the brief spike to 10,120p.
To experience trouble, the share price value needs retreat below 9,300p, such a movement threatening reversal to 8,500p initially with secondary, if broken, down at 7,098 and hopefully another bounce and another go at the future. Hopefully UK politicians don’t try and assist the company, there being no doubt the jingoistic “British Vaccine with a Union Flag” stance actively harmed European distribution potentials, especially with all the Brexit furore in the prior year.
FUTURES
| Time Issued | Market | Price At Issue | Short Entry | Fast Exit | Slow Exit | Stop | Long Entry | Fast Exit | Slow Exit | Stop | Prior |
| 10:35:47PM | GOLD | 1933.31 | ‘cess | ||||||||
| 10:37:13PM | BRENT | 110.74 | |||||||||
| 10:39:21PM | FTSE | 7562.69 | |||||||||
| 10:41:19PM | FRANCE | 6732.8 | 6701 | 6678 | 6627 | 6741 | 6779 | 6791 | 6821 | 6721 | |
| 10:43:26PM | GERMANY | 14611 | |||||||||
| 10:45:20PM | US500 | 4607.97 | 4581 | 4571 | 4549 | 4611 | 4633 | 4651 | 4675 | 4607 | |
| 10:47:07PM | DOW | 35238.5 | |||||||||
| 10:48:48PM | NASDAQ | 15108 | |||||||||
| 10:51:12PM | JAPAN | 27779 | Success |
30/03/2022 FTSE Closed at 7578 points. Change of 0.54%. Total value traded through LSE was: £ 7,437,044,011 a change of -7.97%
29/03/2022 FTSE Closed at 7537 points. Change of 0.86%. Total value traded through LSE was: £ 8,081,315,259 a change of 39.66%
28/03/2022 FTSE Closed at 7473 points. Change of -0.13%. Total value traded through LSE was: £ 5,786,403,389 a change of -6.97%
25/03/2022 FTSE Closed at 7483 points. Change of 0.21%. Total value traded through LSE was: £ 6,219,662,517 a change of -9.68%
24/03/2022 FTSE Closed at 7467 points. Change of 0.09%. Total value traded through LSE was: £ 6,886,600,225 a change of 4.56%
23/03/2022 FTSE Closed at 7460 points. Change of -0.21%. Total value traded through LSE was: £ 6,586,106,936 a change of -2.72%
22/03/2022 FTSE Closed at 7476 points. Change of 0.46%. Total value traded through LSE was: £ 6,769,927,193 a change of 15.91%
SUCCESS above means both FAST & SLOW targets were met. ‘CESS means just the FAST target met and probably the next time it is exceeded, movement to the SLOW target shall commence.
Our commentary is in two sections. Immediately below are today’s updated comments. If our commentary remains valid, the share can be found in the bottom section which has a RED heading. Hopefully, this will mean you no longer need to flip back through previous reports. HYPERLINKS DISABLED IN THIS VERSION
Please remember, all prices are mid-price (halfway between the Buy and Sell). When we refer to a price CLOSING above a specific level, we are viewing the point where we can regard a trend as changing. Otherwise, we are simply speculating on near term trading targets. Our website is www.trendsandtargets.com.
UPDATE. We often give an initial and a secondary price. If the initial is exceeded, we still expect it to fall back but the next time the initial is bettered, the price should continue to the secondary. The converse it true with price drops.
We can be contacted at info@trendsandtargets.com. Spam filters set to maximum so only legit emails get through…
Section One – Outlook Updated Today. Click here for Section Two – Outlook Remains Valid shares
Click Epic to jump to share: LSE:AML Aston Martin** **LSE:AVCT Avacta** **LSE:AZN Astrazeneca** **LSE:BT.A British Telecom** **LSE:FGP Firstgroup** **LSE:FOXT Foxtons** **LSE:GENL Genel** **LSE:GKP Gulf Keystone** **LSE:PHP Primary Health** **LSE:POG Petrop etc** **LSE:POLY Polymetal** **LSE:QFI Quadrise** **
********
Updated charts published on : Aston Martin, Avacta, Astrazeneca, British Telecom, Firstgroup, Foxtons, Genel, Gulf Keystone, Primary Health, Petrop etc, Polymetal, Quadrise,
LSE:AML Aston Martin Close Mid-Price: 1023.5 Percentage Change: -0.58% Day High: 1041 Day Low: 999
In the event of Aston Martin enjoying further trades beyond 1041, the sha ……..
</p
View Previous Aston Martin & Big Picture ***
LSE:AVCT Avacta. Close Mid-Price: 70.5 Percentage Change: + 28.18% Day High: 76.5 Day Low: 55
Target met. All Avacta needs are mid-price trades ABOVE 76.5 to improve a ……..
</p
View Previous Avacta & Big Picture ***
LSE:AZN Astrazeneca. Close Mid-Price: 10160 Percentage Change: + 1.13% Day High: 10164 Day Low: 9977
In the event of Astrazeneca enjoying further trades beyond 10164, the sha ……..
</p
View Previous Astrazeneca & Big Picture ***
LSE:BT.A British Telecom Close Mid-Price: 187.3 Percentage Change: -0.79% Day High: 190.45 Day Low: 185.55
All British Telecom needs are mid-price trades ABOVE 190.45 to improve ac ……..
</p
View Previous British Telecom & Big Picture ***
LSE:FGP Firstgroup. Close Mid-Price: 113.1 Percentage Change: + 0.98% Day High: 114.9 Day Low: 108
Continued trades against FGP with a mid-price ABOVE 114.9 should improve ……..
</p
View Previous Firstgroup & Big Picture ***
LSE:FOXT Foxtons. Close Mid-Price: 41.1 Percentage Change: + 0.24% Day High: 41.35 Day Low: 39.6
Further movement against Foxtons ABOVE 41.35 should improve acceleration ……..
</p
View Previous Foxtons & Big Picture ***
LSE:GENL Genel. Close Mid-Price: 187.2 Percentage Change: + 8.33% Day High: 191 Day Low: 175
Target met. Continued trades against GENL with a mid-price ABOVE 191 shou ……..
</p
View Previous Genel & Big Picture ***
LSE:GKP Gulf Keystone. Close Mid-Price: 259 Percentage Change: + 12.85% Day High: 261 Day Low: 238.5
Target met. In the event of Gulf Keystone enjoying further trades beyond ……..
</p
View Previous Gulf Keystone & Big Picture ***
LSE:PHP Primary Health. Close Mid-Price: 150.4 Percentage Change: + 0.20% Day High: 150.9 Day Low: 148.9
Target met. Continued trades against PHP with a mid-price ABOVE 150.9 sho ……..
</p
View Previous Primary Health & Big Picture ***
LSE:POG Petrop etc Close Mid-Price: 4.2 Percentage Change: -15.66% Day High: 5.5 Day Low: 3.5
Target met. In the event of Petrop etc enjoying further trades beyond 5.5 ……..
</p
View Previous Petrop etc & Big Picture ***
LSE:POLY Polymetal Close Mid-Price: 305.3 Percentage Change: -9.94% Day High: 404.3 Day Low: 305
Target met. Further movement against Polymetal ABOVE 404.3 should improve ……..
</p
View Previous Polymetal & Big Picture ***
LSE:QFI Quadrise Close Mid-Price: 1.49 Percentage Change: -6.87% Day High: 1.54 Day Low: 1.4
Target met. If Quadrise experiences continued weakness below 1.4, it will ……..
</p
View Previous Quadrise & Big Picture ***